Economic Times reports, India’s tech posterboys and cross-town rivals Infosys Technologies and Wipro have shown interest in buying out the US-based high-end analytics company MarketRx. The indicative valuation of MarketRx is seen between $150 million and $160 million.
Lets take a snapshot of the possible deal:
1. Opening the door
This buy will give Wipro’s and Infosys’ outsourcing wing entry into the high end outsourcing segment
2. New Age Transformers
In terms of transformational business process outsourcing deal, MarketRx can give a stronghold to both the biggies.
3. Time to Act Pricey
MarketRx which enjoys high valuations of over 5 times of revenues would have acted pricey in anyway and now when Infy and Wipro both wanting to grab it, it will act as pricier.
To get News, views, analysis, joke, humor, even bitching of outsourcing world Subscribe here
Comment Preview